BIOMAT Database Logo BIOMAT Database Logo

Changes in plasma lipoprotein levels during medication with a glucoside-hydrolase inhibitor (acarbose). 1982

Y Homma, and N Irie, and Y Yano, and N Nakaya, and Y Goto

UI MeSH Term Description Entries
D006951 Hyperlipoproteinemias Conditions with abnormally elevated levels of LIPOPROTEINS in the blood. They may be inherited, acquired, primary, or secondary. Hyperlipoproteinemias are classified according to the pattern of lipoproteins on electrophoresis or ultracentrifugation. Hyperlipoproteinemia
D008074 Lipoproteins Lipid-protein complexes involved in the transportation and metabolism of lipids in the body. They are spherical particles consisting of a hydrophobic core of TRIGLYCERIDES and CHOLESTEROL ESTERS surrounded by a layer of hydrophilic free CHOLESTEROL; PHOSPHOLIPIDS; and APOLIPOPROTEINS. Lipoproteins are classified by their varying buoyant density and sizes. Circulating Lipoproteins,Lipoprotein,Lipoproteins, Circulating
D008079 Lipoproteins, VLDL A class of lipoproteins of very light (0.93-1.006 g/ml) large size (30-80 nm) particles with a core composed mainly of TRIGLYCERIDES and a surface monolayer of PHOSPHOLIPIDS and CHOLESTEROL into which are imbedded the apolipoproteins B, E, and C. VLDL facilitates the transport of endogenously made triglycerides to extrahepatic tissues. As triglycerides and Apo C are removed, VLDL is converted to INTERMEDIATE-DENSITY LIPOPROTEINS, then to LOW-DENSITY LIPOPROTEINS from which cholesterol is delivered to the extrahepatic tissues. Pre-beta-Lipoprotein,Prebeta-Lipoprotein,Prebeta-Lipoproteins,Very Low Density Lipoprotein,Very-Low-Density Lipoprotein,Very-Low-Density Lipoproteins,Lipoprotein VLDL II,Lipoproteins, VLDL I,Lipoproteins, VLDL III,Lipoproteins, VLDL1,Lipoproteins, VLDL2,Lipoproteins, VLDL3,Pre-beta-Lipoproteins,Lipoprotein, Very-Low-Density,Lipoproteins, Very-Low-Density,Pre beta Lipoprotein,Pre beta Lipoproteins,Prebeta Lipoprotein,Prebeta Lipoproteins,VLDL Lipoproteins,VLDL1 Lipoproteins,VLDL2 Lipoproteins,VLDL3 Lipoproteins,Very Low Density Lipoproteins
D008297 Male Males
D009844 Oligosaccharides Carbohydrates consisting of between two (DISACCHARIDES) and ten MONOSACCHARIDES connected by either an alpha- or beta-glycosidic link. They are found throughout nature in both the free and bound form. Oligosaccharide
D002784 Cholesterol The principal sterol of all higher animals, distributed in body tissues, especially the brain and spinal cord, and in animal fats and oils. Epicholesterol
D005260 Female Females
D006026 Glycoside Hydrolases Any member of the class of enzymes that catalyze the cleavage of the glycosidic linkage of glycosides and the addition of water to the resulting molecules. Endoglycosidase,Exoglycosidase,Glycohydrolase,Glycosidase,Glycosidases,Glycoside Hydrolase,Endoglycosidases,Exoglycosidases,Glycohydrolases,Hydrolase, Glycoside,Hydrolases, Glycoside
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

Y Homma, and N Irie, and Y Yano, and N Nakaya, and Y Goto
Lower triglyceride production during carbohydrate-rich diets through acarbose, a glucoside hydrolase inhibitor.
October 1985, Diabete & metabolisme,
Y Homma, and N Irie, and Y Yano, and N Nakaya, and Y Goto
Changes in plasma lipoprotein levels during a hiking expedition in South America.
May 1992, International journal of sports medicine,
Y Homma, and N Irie, and Y Yano, and N Nakaya, and Y Goto
Studies on the alpha-glucoside hydrolase inhibitor, adiposin. III. alpha Glucoside hydrolase inhibitory activity and antibacterial activity in vitro.
September 1982, The Journal of antibiotics,
Y Homma, and N Irie, and Y Yano, and N Nakaya, and Y Goto
Changes in plasma levels of cyclic nucleotides during low-density lipoprotein apheresis.
November 1998, Therapeutic apheresis : official journal of the International Society for Apheresis and the Japanese Society for Apheresis,
Y Homma, and N Irie, and Y Yano, and N Nakaya, and Y Goto
Changes in C-reactive protein plasma levels during low-density lipoprotein apheresis.
August 2003, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy,
Y Homma, and N Irie, and Y Yano, and N Nakaya, and Y Goto
Changes of plasma lipids and lipoprotein levels during danazol treatment for endometriosis.
November 1984, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme,
Y Homma, and N Irie, and Y Yano, and N Nakaya, and Y Goto
Plasma lipoprotein changes during oral contraception.
January 1979, Current medical research and opinion,
Y Homma, and N Irie, and Y Yano, and N Nakaya, and Y Goto
Changes in plasma levels of nitric oxide derivative during low-density lipoprotein apheresis.
November 1997, Therapeutic apheresis : official journal of the International Society for Apheresis and the Japanese Society for Apheresis,
Y Homma, and N Irie, and Y Yano, and N Nakaya, and Y Goto
Changes in bradykinin and prostaglandins plasma levels during dextran-sulfate low-density-lipoprotein apheresis.
March 1997, The International journal of artificial organs,
Y Homma, and N Irie, and Y Yano, and N Nakaya, and Y Goto
Acute changes in plasma levels of hepatocyte growth factor during low-density lipoprotein apheresis.
February 2001, Therapeutic apheresis : official journal of the International Society for Apheresis and the Japanese Society for Apheresis,
Copied contents to your clipboard!